137 related articles for article (PubMed ID: 28640176)
21. Ultrasound-guided radiofrequency ablation (RFA) for inoperable gastrointestinal liver metastases.
Hofer S; Oberholzer C; Beck S; Looser C; Ludwig C
Ultraschall Med; 2008 Aug; 29(4):388-92. PubMed ID: 18785319
[TBL] [Abstract][Full Text] [Related]
22. [CT-guided radiofrequency ablation of liver metastases from colorectal cancer].
Mahnken AH; Bruners P; Tacke JA; Günther RW
Dtsch Med Wochenschr; 2009 May; 134(19):976-80. PubMed ID: 19401962
[TBL] [Abstract][Full Text] [Related]
23. Percutaneous ultrasound-guided radiofrequency ablation (RFA) using saline-perfused (wet) needle electrodes for the treatment of hepatocellular carcinoma--long term experience.
Hänsler J; Frieser M; Tietz V; Uhlke D; Wissniowski TT; Bernatik T; Hahn EG; Strobel D
Ultraschall Med; 2007 Dec; 28(6):604-11. PubMed ID: 18074314
[TBL] [Abstract][Full Text] [Related]
24. Ultrasound-guided thermal radiofrequency ablation (RFA) as an adjunct to systemic chemotherapy for breast cancer liver metastases.
Carrafiello G; Fontana F; Cotta E; Petullà M; Brunese L; Mangini M; Fugazzola C
Radiol Med; 2011 Oct; 116(7):1059-66. PubMed ID: 21643632
[TBL] [Abstract][Full Text] [Related]
25. [Efficacy of radiofrequency ablation of 343 patients with hepatic tumor and the relevant complications].
Chen MH; Yan K; Yang W; Gao W; Dai Y; Wang YB; Zhang H; Huo L; Xing BC; Huang XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 37(3):292-6. PubMed ID: 15968323
[TBL] [Abstract][Full Text] [Related]
26. [Percutaneous radiofrequency ablation with artificial hydrothorax for liver cancer in the hepatic dome].
Han Y; Yu L; Hao YZ; Yang M; Liu S; Deng YB; He LF; Cai JQ; Chen MH
Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):846-9. PubMed ID: 23291135
[TBL] [Abstract][Full Text] [Related]
27. Percutaneous radiofrequency ablation of colorectal hepatic metastases - initial experience. An adjunct technique to systemic chemotherapy for those with inoperable colorectal hepatic metastases.
White TJ; Roy-Choudhury SH; Breen DJ; Cast J; Maraveyas A; Smyth EF; Hartley JE; Monson JR
Dig Surg; 2004; 21(4):314-20. PubMed ID: 15365230
[TBL] [Abstract][Full Text] [Related]
28. Retrospective review of efficacy of radiofrequency ablation for treatment of colorectal cancer liver metastases from a Canadian perspective.
Kwan BY; Kielar AZ; El-Maraghi RH; Garcia LM
Can Assoc Radiol J; 2014 Feb; 65(1):77-85. PubMed ID: 22867961
[TBL] [Abstract][Full Text] [Related]
29. Combined transarterial chemoembolization and radiofrequency ablation for small treatment-naïve hepatocellular carcinoma infeasible for ultrasound-guided radiofrequency ablation: long-term outcomes.
Hyun D; Cho SK; Shin SW; Park KB; Lee SY; Park HS; Do YS
Acta Radiol; 2018 Jul; 59(7):773-781. PubMed ID: 29034691
[TBL] [Abstract][Full Text] [Related]
30. Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma.
Kim JH; Won HJ; Shin YM; Kim KA; Kim PN
AJR Am J Roentgenol; 2011 Feb; 196(2):W205-9. PubMed ID: 21257864
[TBL] [Abstract][Full Text] [Related]
31. Percutaneous ultrasonography-guided radiofrequency ablation of hepatocellular carcinomas: usefulness of image fusion with three-dimensional ultrasonography.
Park HJ; Lee MW; Rhim H; Cha DI; Kang TW; Lim S; Song KD; Lim HK
Clin Radiol; 2015 Apr; 70(4):387-94. PubMed ID: 25582889
[TBL] [Abstract][Full Text] [Related]
32. Percutaneous radiofrequency ablation of ovarian cancer metastasis to the liver: indications, outcomes, and role in patient management.
Gervais DA; Arellano RS; Mueller PR
AJR Am J Roentgenol; 2006 Sep; 187(3):746-50. PubMed ID: 16928940
[TBL] [Abstract][Full Text] [Related]
33. [Echo-guided radiofrequency percutaneous ablation of hepatocellular carcinoma in cirrhosis using a cooled needle].
Marone G; Francica G; D'Angelo V; Iodice G; Pastore P; Altamura G; Cusati B; Siani A
Radiol Med; 1998 Jun; 95(6):624-9. PubMed ID: 9717546
[TBL] [Abstract][Full Text] [Related]
34. Percutaneous ultrasound-guided radiofrequency ablation for patients with liver metastases from gastrointestinal stromal tumors.
Liu L; Wang B; Zhang ZY; Wang S; Wu H; Wang H; Wu W; Yan K; Yang W
Int J Hyperthermia; 2024; 41(1):2292950. PubMed ID: 38159558
[TBL] [Abstract][Full Text] [Related]
35. MR-guided radiofrequency ablation of hepatic malignancies at 1.5 T: initial results.
Mahnken AH; Buecker A; Spuentrup E; Krombach GA; Henzler D; Günther RW; Tacke J
J Magn Reson Imaging; 2004 Mar; 19(3):342-8. PubMed ID: 14994303
[TBL] [Abstract][Full Text] [Related]
36. Safety and Efficacy of Radiofrequency Ablation for Hepatic Metastases from Gastrointestinal Stromal Tumor.
Jung JH; Won HJ; Shin YM; Kim PN
J Vasc Interv Radiol; 2015 Dec; 26(12):1797-1802. PubMed ID: 26603498
[TBL] [Abstract][Full Text] [Related]
37. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma.
Ahn SJ; Lee JM; Lee DH; Lee SM; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
J Hepatol; 2017 Feb; 66(2):347-354. PubMed ID: 27650284
[TBL] [Abstract][Full Text] [Related]
38. Radiofrequency ablation combined with transarterial chemoembolization for unresectable primary liver cancer.
Wang YH; Liu JF; Li F; Li A; Liu Q; Liu DB; Liu DG; Wang YJ
Chin Med J (Engl); 2009 Apr; 122(8):889-94. PubMed ID: 19493409
[TBL] [Abstract][Full Text] [Related]
39. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
[TBL] [Abstract][Full Text] [Related]
40. A comparison of US-guided percutaneous radiofrequency ablation of medium-sized hepatocellular carcinoma with a cluster electrode or a single electrode with a multiple overlapping ablation technique.
Park MJ; Kim YS; Rhim H; Lim HK; Lee MW; Choi D
J Vasc Interv Radiol; 2011 Jun; 22(6):771-9. PubMed ID: 21616430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
